share_log

Procter & Gamble | 8-K: First Quarter Fiscal Year 2025 Results

Procter & Gamble | 8-K: First Quarter Fiscal Year 2025 Results

宝洁 | 8-K： 2025财年第一季度业绩
美股SEC公告 ·  2024/10/18 19:04

Moomoo AI 已提取核心信息

P&G reported Q1 fiscal 2025 net sales of $21.7B, down 1% YoY, while organic sales grew 2%. Core EPS increased 5% to $1.93, though diluted EPS declined 12% to $1.61 due to higher restructuring charges. Operating cash flow reached $4.3B with adjusted free cash flow productivity at 82%.The company maintained its fiscal 2025 guidance, projecting organic sales growth of 3-5% and core EPS growth of 5-7%. P&G expects commodity cost headwinds of approximately $200M after tax, while foreign exchange impact is anticipated to be neutral. The company plans to pay around $10B in dividends and repurchase $6-7B of common shares in fiscal 2025.P&G completed its limited market portfolio restructuring, primarily in Enterprise Markets including Argentina, recording incremental restructuring charges of approximately $1.2B after tax. The company returned nearly $4.4B to shareholders through $2.4B in dividend payments and $1.9B in share repurchases during the quarter.
P&G reported Q1 fiscal 2025 net sales of $21.7B, down 1% YoY, while organic sales grew 2%. Core EPS increased 5% to $1.93, though diluted EPS declined 12% to $1.61 due to higher restructuring charges. Operating cash flow reached $4.3B with adjusted free cash flow productivity at 82%.The company maintained its fiscal 2025 guidance, projecting organic sales growth of 3-5% and core EPS growth of 5-7%. P&G expects commodity cost headwinds of approximately $200M after tax, while foreign exchange impact is anticipated to be neutral. The company plans to pay around $10B in dividends and repurchase $6-7B of common shares in fiscal 2025.P&G completed its limited market portfolio restructuring, primarily in Enterprise Markets including Argentina, recording incremental restructuring charges of approximately $1.2B after tax. The company returned nearly $4.4B to shareholders through $2.4B in dividend payments and $1.9B in share repurchases during the quarter.
宝洁公司报告了2025财年第一季度净销售额为217亿美金，同比下降1%，而有机销售额增长了2%。核心每股收益增长5%至1.93美金，但摊薄后每股收益因重组费用增加而下降12%至1.61美金。经营现金流达到了43亿美金，自由现金流生产力调整为82%。该公司维持了2025财年的指导，预计有机销售额增长为3-5%，核心每股收益增长为5-7%。宝洁预计商品成本压力约为20000万美金税后，而汇率影响预计为中立。公司计划在2025财年支付约100亿美金的分红派息，并回购60-70亿美金的普通股。宝洁完成了其有限市场组合的重组，主要涉及包括阿根廷在内的企业市场，记录了约12亿美金的重组费用税后。公司在本季度通过24亿美金的分红支付和19亿美金的股票回购，向股东回馈近44亿美金。
宝洁公司报告了2025财年第一季度净销售额为217亿美金，同比下降1%，而有机销售额增长了2%。核心每股收益增长5%至1.93美金，但摊薄后每股收益因重组费用增加而下降12%至1.61美金。经营现金流达到了43亿美金，自由现金流生产力调整为82%。该公司维持了2025财年的指导，预计有机销售额增长为3-5%，核心每股收益增长为5-7%。宝洁预计商品成本压力约为20000万美金税后，而汇率影响预计为中立。公司计划在2025财年支付约100亿美金的分红派息，并回购60-70亿美金的普通股。宝洁完成了其有限市场组合的重组，主要涉及包括阿根廷在内的企业市场，记录了约12亿美金的重组费用税后。公司在本季度通过24亿美金的分红支付和19亿美金的股票回购，向股东回馈近44亿美金。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    The Beauty Health
    SKIN
    -- 1.375
    朴荷生物科技
    PHH
    -- 13.190
    European Wax Center
    EWCZ
    -- 3.985
    Longevity Health Holdings
    XAGE
    -- 0.125
    宝洁
    PG
    -- 169.775
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股财报季火热：惊喜盈利能否延续涨势？
    1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？ 展开
    中国两会：会议前后股票价格走势的主要要点